Lost your password? (close)

News and Press Releases

  • March 9, 2016: Evidera Annouces Release of FDA Draft Guidance on Use of the “E-RS: COPD” to Measure Respiratory Symptoms in Stable COPD. Available here.
  • May 11, 2015: Evidera Announces Release of EMA Draft Opinion on Two Patient-reported Outcome (PRO) Measures for Evaluating New Treatments for COPD. Available here.
  • June 13, 2014: Drug Development Tools and the EXACT PRO Initiative: A Conversation with Richard Moscicki, Deputy Center Director for Science Operations, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA). Available here.
  • January 14, 2014: Evidera Announces Release of FDA Draft Guidance on Use of the “EXACT” to Measure Symptoms of COPD Exacerbations. Available here.
  • July 8, 2013: UBC’S HEOR/Market Access Division Acquired by Symphony Technology Group — Introducing Evidera. Available here.
© 2017 Evidera     +1 301 654 9729 (US)     +44 (0) 208 576 5000 (EU)